Amgen reported earnings of $ 6.45 per AMGN share on Nov 3, 2026, beating analysts' expectations by
| Report Date | Nov 3, 2026 |
|---|---|
| Forecasted EPS | $ 5.79 |
| Earnings Per Share (Surprise) | $ 6.45 (+$ 0.66) |
| Last Year's EPS | $ 5.46 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Amgen beat analysts’ expectations 83 times and fell short of expectations 14 time(s). Amgen reported earnings per share of $ 6.45 in the last report surpassing an estimated EPS of $ 5.79 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 3, 2026 | $ 5.79 | $ 6.45 | $ 5.64 | |
| Aug 4, 2026 | $ 5.62 | $ 6.29 | $ 6.02 | |
| Apr 30, 2026 | $ 4.77 | $ 5.15 | $ 4.90 | |
| Feb 3, 2026 | $ 4.73 | $ 5.29 | $ 5.31 | |
| Nov 4, 2025 | $ 5.02 | $ 5.64 | $ 5.58 | |
| Aug 5, 2025 | $ 5.28 | $ 6.02 | $ 4.97 | |
| May 1, 2025 | $ 4.27 | $ 4.90 | $ 3.96 | |
| Feb 4, 2025 | $ 5.04 | $ 5.31 | $ 4.71 | |
| Oct 30, 2024 | $ 5.11 | $ 5.58 | $ 4.96 | |
| Aug 6, 2024 | $ 4.98 | $ 4.97 | $ 5.00 | |
| May 2, 2024 | $ 3.88 | $ 3.96 | $ 3.98 | |
| Feb 6, 2024 | $ 4.59 | $ 4.71 | $ 4.09 | |
| Oct 31, 2023 | $ 4.65 | $ 4.96 | $ 4.70 | |
| Aug 3, 2023 | $ 4.44 | $ 5.00 | $ 4.65 | |
| Apr 27, 2023 | $ 3.85 | $ 3.98 | $ 4.25 | |
| Jan 31, 2023 | $ 4.04 | $ 4.09 | $ 4.36 | |
| Nov 3, 2022 | $ 4.44 | $ 4.70 | $ 4.67 | |
| Aug 4, 2022 | $ 4.40 | $ 4.65 | $ 4.38 | |
| Apr 27, 2022 | $ 4.22 | $ 4.25 | $ 3.70 | |
| Feb 7, 2022 | $ 4.14 | $ 4.36 | $ 3.81 |
Amgen’s stock was trading at $ 465.45 on Nov 2, 2026 a day before the last earnings report was released.Following the release of the earnings report, AMGN’s price increased to $ 478.48 on Nov 4, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 3, 2026 | $ 6.45 | $ 465.45 | $ 478.48 | |
| Aug 4, 2026 | $ 6.29 | $ 378.87 | $ 407.83 | |
| Apr 30, 2026 | $ 5.15 | $ 338.02 | $ 329.82 | |
| Feb 3, 2026 | $ 5.29 | $ 344.68 | $ 366.20 | |
| Nov 4, 2025 | $ 5.64 | $ 296.30 | $ 319.86 | |
| Aug 5, 2025 | $ 6.02 | $ 301.94 | $ 284.67 | |
| May 1, 2025 | $ 4.90 | $ 290.92 | $ 281.22 | |
| Feb 4, 2025 | $ 5.31 | $ 288.87 | $ 307.81 | |
| Oct 30, 2024 | $ 5.58 | $ 316.00 | $ 320.16 | |
| Aug 6, 2024 | $ 4.97 | $ 325.22 | $ 312.50 | |
| May 2, 2024 | $ 3.96 | $ 277.37 | $ 311.29 | |
| Feb 6, 2024 | $ 4.71 | $ 321.97 | $ 295.87 | |
| Oct 31, 2023 | $ 4.96 | $ 263.19 | $ 260.84 | |
| Aug 3, 2023 | $ 5.00 | $ 230.41 | $ 243.28 | |
| Apr 27, 2023 | $ 3.98 | $ 238.80 | $ 239.74 | |
| Jan 31, 2023 | $ 4.09 | $ 251.59 | $ 246.41 | |
| Nov 3, 2022 | $ 4.70 | $ 269.01 | $ 269.04 | |
| Aug 4, 2022 | $ 4.65 | $ 247.14 | $ 246.25 | |
| Apr 27, 2022 | $ 4.25 | $ 249.87 | $ 238.13 | |
| Feb 7, 2022 | $ 4.36 | $ 222.11 | $ 241.01 |
Amgen released its most recent earnings reports in November 2026, August 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Amgen beat analysts’ expectations during the last earnings period by
